Official announcements
Safety warnings
|
messages in brief
|
20/12/2013
The preparation Eldisin 5 mg dry ampoules (active ingredient: vindesine sulfate) has been approved in Austria since March 29, 1984. Vindesine is a cytostatic drug from the group of vinca alkaloids and has proven effective primarily in combination…
Recall
|
Medicines
|
19/12/2013
In a letter dated December 19, 2013, the marketing authorization holder informed its customers that an elevated level of a known degradation product of the active ingredient azithromycin has been detected in some vials and that a voluntary recall is…
Safety warnings
|
Blood & Tissue
|
18/12/2013
Two autochthonous cases confirmed by PCR in Saint Martin.
Replacement
|
Medicines
|
17/12/2013
WABOSAN Arzneimittelvertriebs GmbH has informed its supplied customers by letter dated 12.12.2013 that yellow-orange precipitations have been observed in batch Y260 in individual cases and therefore a precautionary recall is being carried out. This…
Veterinary Medicines
|
11/12/2013
In a letter dated December 9, 2013, the distributor informed its customers that in some cases the wrong pump sizes were included in batch EDEG-2.Packages of the 6 ml glass vials could contain pumps for the 33 ml vials, which could result in a 3.1 to…
Safety warnings
|
Blood & Tissue
|
04/12/2013
All preventive measures for WNV transmission halted. Those entering the country from the Americas and Canada will continue to be barred from donating for 28 days.
Replacement
|
Medicines
|
20/11/2013
The marketing authorization holder informed its supplied customers in a letter dated November 20, 2013, that the above-mentioned batches would be recalled from the market because values for the parameter particle size outside the approved…
Medicines
|
19/11/2013
The company responsible for distribution, sigma-tau ArzneimittelGmbH, 40212 Düsseldorf, Germany, informed its supplied customers on November 15, 2013, that individual containers of the above-mentioned batches may have fine cracks that may lead to…
Recall
|
Medicines
|
12/11/2013
Due to a possible quality defect, the companies Sigma-Tau Arzneimittel GmbH and Sigma-Tau Rare Diseases S.A. have decided to recall the above mentioned batches of Oncaspar® Injection Solution.Both companies have been informed by the manufacturer of…
Recall
|
Medicines
|
11/11/2013
Due to a technical defect, there is a possibility in a small number of Jext epinephrine auto-injectors that the epinephrine is not correctly applied to the muscle when the auto-injector is triggered.
